Cell News and Research

RSS

EHSI to sign definitive agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it is moving forward with negotiations toward a profit participation agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

11 Mar 2011

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

Caliper Life Sciences, Inc. and HistoRx, Inc., today announced a collaboration to co-develop a new generation of tissue-based imaging and analysis solutions, based on immuno-fluorescence, that will deliver accurate, quantitative, and reproducible measurements of proteins in tissue samples.

11 Mar 2011

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

Scientists from The Scripps Research Institute have determined a new structure from a medically important superfamily of proteins. The structure should help instruct the design of a new kind of therapeutics for conditions ranging from Parkinson's disease to inflammation.

11 Mar 2011

Researchers create protein molecule for new anti-inflammatory therapies

Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.

11 Mar 2011

SAP may serve as effective nanomaterial to prevent prostate cancer spread

When prostate cancer stem cells were enclosed in self-assembling nanomaterials made of peptides, the SAP stopped cancer stem cell colony formation and also stopped the division of cancer cells in laboratory cultures.

11 Mar 2011

Wnt1 protein can improve function of endothelial progenitor cells

Circulating through the bloodstream of every human being is a rare and powerful type of cell, one that can actually create new blood vessels to bypass blockages that cause heart attacks and peripheral artery disease.

10 Mar 2011

Preliminary phase I trial results show safety of bone marrow stem cells in children with TBI

Stem cells derived from a patient's own bone marrow were safely used in pediatric patients with traumatic brain injury, according to results of a Phase I clinical trial at The University of Texas Health Science Center at Houston.

10 Mar 2011

Scientists develop new model for neurodegenerative disease

A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.

10 Mar 2011

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

ISCO achieves major milestone in stem cell banking program

International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.

10 Mar 2011

Scientists mark important step toward universal RBCs production

Scientists are reporting an "important step" toward development of a universal blood product that would eliminate the need to "type" blood to match donor and recipient before transfusions.

10 Mar 2011

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia, relapse remains a leading cause of death from the disease. Work led by St. Jude Children's Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.

10 Mar 2011

Scientists identify chemical compound that may lead to cancer-fighting drugs

Researchers at UT Southwestern Medical Center have identified a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.

10 Mar 2011

U.S. researchers who collaborate with international scientists more likely to receive greater recognition

U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.

10 Mar 2011

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

California Institute of Technology graduate student Guoan Zheng is the recipient of the 2011 $30,000 Lemelson-MIT Caltech Student Prize.

10 Mar 2011

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has initiated a Phase I clinical study with SAN-300, its anti-VLA-1 antibody.

10 Mar 2011

New research identifies major surgeries that face risk of developing postoperative sepsis

Sepsis, a life-threatening bacterial infection of the blood, is an unwanted and costly complication to patients and the health care system. New research at UMDNJ-Robert Wood Johnson Medical School has identified major elective surgeries in which sepsis occurs most often post-procedure, along with extenuating conditions such as age, gender and type of hospital that increase the risk for sepsis.

10 Mar 2011

Professor utilizes $300,000 N.Y. grant to study adult neural stem cells

Rensselaer Polytechnic Institute Assistant Professor of Biomedical Engineering Deanna Thompson is utilizing more than $300,000 in New York state funding as part of the state stem cell research program, NYSTEM, to study adult neural stem cells.

10 Mar 2011

PQC: Americans express rising concern about hospital acquired infections

Despite significant advances made during the last several years, most Americans view the care delivered in America today as merely adequate - with 20 percent rating care as poor compared to only 8 percent who rated care as excellent. Americans expressed rising concern about hospital acquired infections, sepsis and other preventable conditions, according to new research released today by the Partnership for Quality Care.

10 Mar 2011

Cell News and Research

EHSI to sign definitive agreement with OceanBASIS

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

Researchers create protein molecule for new anti-inflammatory therapies

SAP may serve as effective nanomaterial to prevent prostate cancer spread

Wnt1 protein can improve function of endothelial progenitor cells

Preliminary phase I trial results show safety of bone marrow stem cells in children with TBI

Scientists develop new model for neurodegenerative disease

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Idera reports $6.0 million net loss for fourth quarter 2010

ISCO achieves major milestone in stem cell banking program

Scientists mark important step toward universal RBCs production

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Scientists identify chemical compound that may lead to cancer-fighting drugs

U.S. researchers who collaborate with international scientists more likely to receive greater recognition

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

New research identifies major surgeries that face risk of developing postoperative sepsis

Professor utilizes $300,000 N.Y. grant to study adult neural stem cells

PQC: Americans express rising concern about hospital acquired infections

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News